MDC and ZEISS join forces to catapult complex medicine development
13 Aug 2022
Medicines Discovery Catapult (MDC) the not-for-profit organisation established by Innovate UK, has joined forces with the German-based ZEISS to use advanced microscopy solutions to boost drug discovery and complex medicine development.
MDC will work with ZEISS Research Microscopy Solutions unit, headquartered in Jena.
The catapult has established specialist advanced microscopy capabilities at its Alderley Park lab facilities, employing ZEISS microscopes to develop advanced microscopy capability for drug discovery. The work will simultaneously enable the further development of ZEISS’s instruments.
Chief Scientist at MDC Dr Martin Main said advanced microscopy offered an array of benefits.
“MDC’s Advanced Microscopy capability allows UK drug discovery innovators access to this critical R&D resource to progress their targets more efficiently and effectively, bringing better treatments to patients, faster.”
“Through this partnership, we will push the boundaries of advanced microscopy in drug discovery, further driving the adoption of new scientific tools and techniques for drug discovery.”
